サマリー

自己免疫疾患治療薬の世界市場 2023-2027
Technavioは、自己免疫薬市場をモニターしており、2022年から2027年の間に29314.5百万ドル、予測期間中のCAGRは6.39%で加速して成長すると予測しています。当レポートでは、自己免疫疾患薬市場について、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、強力な研究開発パイプライン、生物学的製剤の標的治療メカニズム、手頃な価格のバイオシミラーの導入によって牽引されています。
Technavioの自己免疫薬市場は以下のようにセグメント化されています：
治療領域別
- 関節リュウマチ
- 多発性硬化症
- 乾癬
- 炎症性腸疾患（Inflammatory bowel disease
- その他
流通チャネル別
- 病院
- ファーマシー
- ドラッグストア・調剤薬局
- オンライン
ジオグラフィー別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、自己免疫疾患治療薬のコスト削減が、今後数年間の自己免疫疾患治療薬市場の成長を促進する主要因の1つであることを明らかにしています。また、TNFα阻害剤による市場支配と新薬の開発・承認が、市場の大きな需要につながるとしています。
Technavioは、複数のソースからのデータを主要パラメータの分析によって調査、合成、総括する方法で、市場の詳細な姿を提示します。当レポートでは、自己免疫疾患薬市場について、以下の分野を取り上げています：
- 自己免疫薬市場のサイジング
- 自己免疫疾患治療薬市場予測
- 自己免疫疾患薬市場の産業分析
Technavioの強固なベンダー分析は、クライアントが市場での地位を向上させることを目的としており、これに沿って本レポートでは、AbbVie Inc.、AdvaCare Pharma、Amgen Inc.、AstraZeneca Plc、Bristol Myers Squibb Co.を含むいくつかの主要自己免疫薬市場ベンダーについて詳細に分析を行っています、Cardinal Health Inc.、Delphis Pharmaceutical India、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Hikma Pharmaceuticals Plc、Johnson and Johnson、Medexus Pharmaceuticals Inc. Parvus Therapeutics Inc.、Promethus Laboratories Inc.、Regenon Pharmaceuticals Inc.、SanoFi SA、Takeda Pharmaceutical Co.Ltd.、Teva Pharmaceutical Industries Ltd.、Wellona Pharmaです。また、自己免疫薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要な参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/autoimmune-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global autoimmune drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global autoimmune drugs market 2017 - 2021 ($ million)
o 4.2 Therapy area Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
o 4.3 Distribution channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Therapy Area
o 6.1 Market segments
o Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
o 6.2 Comparison by Therapy Area
o Exhibit 32: Chart on Comparison by Therapy Area
o Exhibit 33: Data Table on Comparison by Therapy Area
o 6.3 Rheumatoid arthritis - Market size and forecast 2022-2027
o Exhibit 34: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
o 6.4 Multiple sclerosis - Market size and forecast 2022-2027
o Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
o 6.5 Psoriasis - Market size and forecast 2022-2027
o Exhibit 42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
o 6.6 Inflammatory bowel disease - Market size and forecast 2022-2027
o Exhibit 46: Chart on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapy Area
o Exhibit 54: Market opportunity by Therapy Area ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 57: Chart on Comparison by Distribution Channel
o Exhibit 58: Data Table on Comparison by Distribution Channel
o 7.3 Hospital - Market size and forecast 2022-2027
o Exhibit 59: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Hospital - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
o 7.4 Pharmacy - Market size and forecast 2022-2027
o Exhibit 63: Chart on Pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Pharmacy - Year-over-year growth 2022-2027 (%)
o 7.5 Drug store/Retail pharmacy - Market size and forecast 2022-2027
o Exhibit 67: Chart on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
o 7.6 Online - Market size and forecast 2022-2027
o Exhibit 71: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Distribution Channel
o Exhibit 75: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 77: Chart on Market share by geography 2022-2027 (%)
o Exhibit 78: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 79: Chart on Geographic comparison
o Exhibit 80: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 81: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 97: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 Canada - Market size and forecast 2022-2027
o Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 109: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 113: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 114: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 115: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 116: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 117: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 118: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 119: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 120: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 121: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 122: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 123: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 124: AbbVie Inc. - Overview
o Exhibit 125: AbbVie Inc. - Product / Service
o Exhibit 126: AbbVie Inc. - Key news
o Exhibit 127: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 128: Amgen Inc. - Overview
o Exhibit 129: Amgen Inc. - Product / Service
o Exhibit 130: Amgen Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 131: AstraZeneca Plc - Overview
o Exhibit 132: AstraZeneca Plc - Product / Service
o Exhibit 133: AstraZeneca Plc - Key news
o Exhibit 134: AstraZeneca Plc - Key offerings
o 12.6 Bristol Myers Squibb Co.
o Exhibit 135: Bristol Myers Squibb Co. - Overview
o Exhibit 136: Bristol Myers Squibb Co. - Product / Service
o Exhibit 137: Bristol Myers Squibb Co. - Key news
o Exhibit 138: Bristol Myers Squibb Co. - Key offerings
o 12.7 Cardinal Health Inc.
o Exhibit 139: Cardinal Health Inc. - Overview
o Exhibit 140: Cardinal Health Inc. - Business segments
o Exhibit 141: Cardinal Health Inc. - Key news
o Exhibit 142: Cardinal Health Inc. - Key offerings
o Exhibit 143: Cardinal Health Inc. - Segment focus
o 12.8 Delphis Pharmaceutical India
o Exhibit 144: Delphis Pharmaceutical India - Overview
o Exhibit 145: Delphis Pharmaceutical India - Product / Service
o Exhibit 146: Delphis Pharmaceutical India - Key offerings
o 12.9 Eli Lilly and Co.
o Exhibit 147: Eli Lilly and Co. - Overview
o Exhibit 148: Eli Lilly and Co. - Product / Service
o Exhibit 149: Eli Lilly and Co. - Key offerings
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 GlaxoSmithKline Plc
o Exhibit 155: GlaxoSmithKline Plc - Overview
o Exhibit 156: GlaxoSmithKline Plc - Business segments
o Exhibit 157: GlaxoSmithKline Plc - Key offerings
o Exhibit 158: GlaxoSmithKline Plc - Segment focus
o 12.12 Hikma Pharmaceuticals Plc
o Exhibit 159: Hikma Pharmaceuticals Plc - Overview
o Exhibit 160: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 161: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 162: Hikma Pharmaceuticals Plc - Segment focus
o 12.13 Johnson and Johnson
o Exhibit 163: Johnson and Johnson - Overview
o Exhibit 164: Johnson and Johnson - Business segments
o Exhibit 165: Johnson and Johnson - Key news
o Exhibit 166: Johnson and Johnson - Key offerings
o Exhibit 167: Johnson and Johnson - Segment focus
o 12.14 Parvus Therapeutics Inc.
o Exhibit 168: Parvus Therapeutics Inc. - Overview
o Exhibit 169: Parvus Therapeutics Inc. - Product / Service
o Exhibit 170: Parvus Therapeutics Inc. - Key offerings
o 12.15 Sanofi SA
o Exhibit 171: Sanofi SA - Overview
o Exhibit 172: Sanofi SA - Business segments
o Exhibit 173: Sanofi SA - Key news
o Exhibit 174: Sanofi SA - Key offerings
o Exhibit 175: Sanofi SA - Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 176: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 177: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 178: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 179: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 185: Inclusions checklist
o Exhibit 186: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 187: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 188: Research methodology
o Exhibit 189: Validation techniques employed for market sizing
o Exhibit 190: Information sources
o 13.5 List of abbreviations
o Exhibit 191: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global autoimmune drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy Area - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy Area
Exhibits33: Data Table on Comparison by Therapy Area
Exhibits34: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapy Area ($ million)
Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Distribution Channel
Exhibits58: Data Table on Comparison by Distribution Channel
Exhibits59: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits75: Market opportunity by Distribution Channel ($ million)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share by geography 2022-2027 (%)
Exhibits78: Data Table on Market share by geography 2022-2027 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits113: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits114: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits115: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits116: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits117: Market opportunity by geography ($ million)
Exhibits118: Impact of drivers and challenges in 2022 and 2027
Exhibits119: Overview on Criticality of inputs and Factors of differentiation
Exhibits120: Overview on factors of disruption
Exhibits121: Impact of key risks on business
Exhibits122: Vendors covered
Exhibits123: Matrix on vendor position and classification
Exhibits124: AbbVie Inc. - Overview
Exhibits125: AbbVie Inc. - Product / Service
Exhibits126: AbbVie Inc. - Key news
Exhibits127: AbbVie Inc. - Key offerings
Exhibits128: Amgen Inc. - Overview
Exhibits129: Amgen Inc. - Product / Service
Exhibits130: Amgen Inc. - Key offerings
Exhibits131: AstraZeneca Plc - Overview
Exhibits132: AstraZeneca Plc - Product / Service
Exhibits133: AstraZeneca Plc - Key news
Exhibits134: AstraZeneca Plc - Key offerings
Exhibits135: Bristol Myers Squibb Co. - Overview
Exhibits136: Bristol Myers Squibb Co. - Product / Service
Exhibits137: Bristol Myers Squibb Co. - Key news
Exhibits138: Bristol Myers Squibb Co. - Key offerings
Exhibits139: Cardinal Health Inc. - Overview
Exhibits140: Cardinal Health Inc. - Business segments
Exhibits141: Cardinal Health Inc. - Key news
Exhibits142: Cardinal Health Inc. - Key offerings
Exhibits143: Cardinal Health Inc. - Segment focus
Exhibits144: Delphis Pharmaceutical India - Overview
Exhibits145: Delphis Pharmaceutical India - Product / Service
Exhibits146: Delphis Pharmaceutical India - Key offerings
Exhibits147: Eli Lilly and Co. - Overview
Exhibits148: Eli Lilly and Co. - Product / Service
Exhibits149: Eli Lilly and Co. - Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. - Overview
Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits152: F. Hoffmann La Roche Ltd. - Key news
Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits155: GlaxoSmithKline Plc - Overview
Exhibits156: GlaxoSmithKline Plc - Business segments
Exhibits157: GlaxoSmithKline Plc - Key offerings
Exhibits158: GlaxoSmithKline Plc - Segment focus
Exhibits159: Hikma Pharmaceuticals Plc - Overview
Exhibits160: Hikma Pharmaceuticals Plc - Business segments
Exhibits161: Hikma Pharmaceuticals Plc - Key offerings
Exhibits162: Hikma Pharmaceuticals Plc - Segment focus
Exhibits163: Johnson and Johnson - Overview
Exhibits164: Johnson and Johnson - Business segments
Exhibits165: Johnson and Johnson - Key news
Exhibits166: Johnson and Johnson - Key offerings
Exhibits167: Johnson and Johnson - Segment focus
Exhibits168: Parvus Therapeutics Inc. - Overview
Exhibits169: Parvus Therapeutics Inc. - Product / Service
Exhibits170: Parvus Therapeutics Inc. - Key offerings
Exhibits171: Sanofi SA - Overview
Exhibits172: Sanofi SA - Business segments
Exhibits173: Sanofi SA - Key news
Exhibits174: Sanofi SA - Key offerings
Exhibits175: Sanofi SA - Segment focus
Exhibits176: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits177: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits178: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits179: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits184: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations